https://scholars.lib.ntu.edu.tw/handle/123456789/627710
標題: | Inhibition of Prostaglandin Reductase 2, a Putative Oncogene Overexpressed in Human Pancreatic Adenocarcinoma, Induces Oxidative Stress-Mediated Cell Death Involving xCT and CTH Gene Expressions through 15-Keto-PGE2 | 作者: | Chang, Emily Yun-Chia YI-CHENG CHANG CHIA-TUNG SHUN YU-WEN TIEN Tsai, Shu-Huei Hee, Siow-Wey Chen, Ing-Jung LEE-MING CHUANG |
關鍵字: | ACTIVATED-RECEPTOR-GAMMA; CANCER-CELLS; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; PPAR-GAMMA; UP-REGULATION; CYSTINE/GLUTAMATE ANTIPORTER; COLORECTAL-CANCER; CARCINOMA GROWTH; APOPTOSIS; PATHWAY | 公開日期: | 2016 | 出版社: | PUBLIC LIBRARY SCIENCE | 卷: | 11 | 期: | 1 | 來源出版物: | PloS one | 摘要: | Prostaglandin reductase 2 (PTGR2) is the enzyme that catalyzes 15-keto-PGE2, an endogenous PPARγ ligand, into 13,14-dihydro-15-keto-PGE2. Previously, we have reported a novel oncogenic role of PTGR2 in gastric cancer, where PTGR2 was discovered to modulate ROS-mediated cell death and tumor transformation. In the present study, we demonstrated the oncogenic potency of PTGR2 in pancreatic cancer. First, we observed that the majority of the human pancreatic ductal adenocarcinoma tissues was stained positive for PTGR2 expression but not in the adjacent normal parts. In vitro analyses showed that silencing of PTGR2 expression enhanced ROS production, suppressed pancreatic cell proliferation, and promoted cell death through increasing 15-keto-PGE2. Mechanistically, silencing of PTGR2 or addition of 15-keto-PGE2 suppressed the expressions of solute carrier family 7 member 11 (xCT) and cystathionine gamma-lyase (CTH), two important providers of intracellular cysteine for the generation of glutathione (GSH), which is widely accepted as the first-line antioxidative defense. The oxidative stress-mediated cell death after silencing of PTGR2 or addition of 15-keto-PGE2 was further abolished after restoring intracellular GSH concentrations and cysteine supply by N-acetyl-L-cysteine and 2-Mercaptomethanol. Our data highlight the therapeutic potential of targeting PTGR2/15-keto-PGE2 for pancreatic cancer. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/627710 | ISSN: | 1932-6203 | DOI: | 10.1371/journal.pone.0147390 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。